GeneQuine Biotherapeutics GmbH, R&D Site in Luckenwalde

https://www.genequine.com

GeneQuine Biotherapeutics GmbH is a biotech company focused on the development of innovative gene therapies for treatment of musculoskeletal disorders. GeneQuine’s aim is to use its gene therapy platform to established sustained production of therapeutic proteins locally in the tissues or organs where they are needed. The lead candidate GQ-303 is being developed as a locally administered treatment for osteoarthritis and has demonstrated the potential to be a symptomatic and disease-modifying treatment in several animal models. In 2017, Flexion Therapeutics, Inc. acquired GeneQuine’s then-lead program for osteoarthritis, which is based on the same gene therapy vector technology as GQ-303 and is currently in clinical Phase 1 testing. GeneQuine is headquartered in Hamburg, Germany and has sites at Luckenwalde (greater Berlin area), Germany and Liège, Belgium. *

	Start	2021-01-26 existent
	End	2023-05-08 renamed
	Group	Pacira (Group)
	Today	GQ Biotherapeutics GmbH, R&D Site in Luckenwalde
	Successor	GQ Biotherapeutics GmbH, R&D Site in Luckenwalde
	Industry	gene therapy
	Industry 2	HCAd gene therapy vector platform (high-capacity adenovirus; formerly HDAd vector platform
	Person	Guse, Kilian (GeneQuine Biotherapeutics 201210 Managing Director)

	Region	Luckenwalde
	Country	Germany
	City	n. a. Luckenwalde
		Address record changed: 2021-01-26

Basic data	Employees	n. a.

		* Document for »About Section«: High-Tech Gründerfonds Management GmbH. (1/26/21). "Press Release: GeneQuine Biotherapeutics Secures more than €9 Million in Series A Financing and Non-Dilutive Funding to Advance Gene Therapy Pipeline for Musculoskeletal Diseases".

		Record changed: 2025-03-30

Picture Swiss Biotech Association Global Village 2025 SBD25 Basel 650x200px

More documents for Pacira (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)